MARKET

VYGR

VYGR

Voyager Therapeutics Inc
NASDAQ
3.460
+0.140
+4.22%
Closed 18:29 06/11 EDT
OPEN
3.320
PREV CLOSE
3.320
HIGH
3.490
LOW
3.260
VOLUME
650.61K
TURNOVER
0
52 WEEK HIGH
5.55
52 WEEK LOW
2.830
MARKET CAP
209.06M
P/E (TTM)
-1.7491
1D
5D
1M
3M
1Y
5Y
1D
Voyager Therapeutics CEO to present fireside chat at H.C. Wainwright Neuro Perspectives conference webcast
PUBT · 1d ago
Voyager to Present at H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference
Barchart · 1d ago
Voyager Therapeutics Expands Authorized Shares After Stockholder Vote
TipRanks · 2d ago
Voyager Therapeutics shareholders approve authorized share increase at annual meeting
PUBT · 2d ago
As the GLP-1 race heats up, how can investors position themselves for the next wave of innovation?
Seeking Alpha · 2d ago
Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Ovid Therapeutics (OVID) and Establishment Labs Holdings (ESTA)
TipRanks · 4d ago
Weekly Report: what happened at VYGR last week (0601-0605)?
Weekly Report · 4d ago
Guggenheim Sticks to Its Buy Rating for Voyager Therapeutics (VYGR)
TipRanks · 06/02 11:39
More
About VYGR
Voyager Therapeutics, Inc. is a biotechnology company engaged in leveraging the power of human genetics to modify the course of neurological diseases. The Company’s pipeline includes programs for Alzheimer’s disease, Friedreich’s ataxia, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and multiple other diseases of the central nervous system. Many of its programs are derived from its Tropism Redirection of AAV by Cell-type-specific Expression of RNA (TRACER) adeno-associated virus (AAV) capsid discovery platform, which is used to generate capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Its pipeline of programs includes Anti-Tau Antibody (VY7523), Tau Silencing Gene Therapy (VY1706), SOD1 Silencing Gene Therapy Program, Vectorized Anti-Amyloid Antibody Early Research Program, Friedreich’s Ataxia Program: VY-FXN01, GBA1 Gene Replacement Program, HD Program and others.

Webull offers Voyager Therapeutics Inc stock information, including NASDAQ: VYGR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VYGR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VYGR stock methods without spending real money on the virtual paper trading platform.